Results 31 to 40 of about 2,997,892 (269)

Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification

PCN Reports, 2023
Psychosis is recognized as one of the largest contributors to nonfatal health loss, and early identification can largely improve routine clinical activity by predicting the psychotic course and guiding treatment.
TianHong Zhang, LiHua Xu, XiaoChen Tang, YanYan Wei, YeGang Hu, HuiRu Cui, YingYing Tang, ChunBo Li, JiJun Wang   +8 more
doaj   +1 more source

Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders.

Journal of Abnormal Psychology, 2020
Mismatch negativity (MMN) amplitude has been widely shown to be diminished in schizophrenia and, more recently, in other psychotic disorders. Although there is considerable evidence linking MMN reduction to cognitive and functional deficits in ...
Kayla R. Donaldson, K. Novak, D. Foti, Maya A. Marder, G. Perlman, R. Kotov, Aprajita Mohanty   +6 more
semanticscholar   +1 more source

Elevated pulse pressure and its associations with demographic and clinical parameters in a clinically representative sample of outpatients with psychotic disorders

BJPsych Open, 2022
Elevated pulse pressure is associated with metabolic and neurocognitive diseases. Preliminary small-scale studies among patients with psychotic disorders have indicated that these patients had an increased pulse pressure compared with controls.
Christopher Holmberg, Jarl Torgerson, Andreas Gremyr   +2 more
doaj   +1 more source

Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)

Pharmaceuticals, 2023
Sarcosine (N-methylglycine), a glutamatergic modulator, reduces the primary negative symptoms of schizophrenia. These beneficial changes might be mediated by trophic factors such as epidermal growth factor (EGF).
Agnieszka Pawlak, Bartosz Kaczmarek, Adam Wysokiński, Dominik Strzelecki   +3 more
doaj   +1 more source

20 years of daily hospital for non-psychotic disorders, organisational structure and treatment modalities

European Psychiatry, 2022
Introduction Anxiety and depressive disorders are among the most prevalent psychiatric disorders, yet there aren’t many studies adressing treatment modalities in daily hospitals.
S. Caratan, S. Kocijan Lovko, A. Ivrlač, L. Goršić, T. Matoš   +4 more
doaj   +1 more source

TMS in Psychotic Disorders [PDF]

, 2020
Schizophrenia is one of the most disabling mental disorders with a large burden of disease. Treatment options for positive, negative and cognitive symptoms of schizophrenia are limited, and a third of the patients with schizophrenia respond insufficiently to antipsychotic medications.
André Aleman, Jozarni J. Dlabac-de Lange   +1 more
openaire   +2 more sources

Evaluation of the relationship between vitamin D concentration and cognitive performance in community dwelling elderly people

Psychiatria i Psychologia Kliniczna, 2019
Introduction: People over the age of 65 are at a significant risk of vitamin D deficiency. This a result of many factors. Based on the studies conducted so far, it can be concluded that there is a relationship between vitamin D deficiency and the elderly
Katarzyna Antczak-Domagała, Joanna Magierska, Anna Łucka, Jaśmina Arabska, Iwona Kłoszewska, Tomasz Sobów, Radosław Magierski   +6 more
doaj   +1 more source

Early Maladaptive Schemas and Schema Modes among People with Histories of Suicidality and the Possibility of a Universal Pattern: A Systematic Review

Brain Sciences, 2023
Background: The identification of variables affecting suicidality and the search for interventions to reduce suicide risk are priorities among mental health researchers.
Anna Grażka, Dominik Strzelecki
doaj   +1 more source

Thought Suppression in Primary Psychotic Disorders and Substance/Medication Induced Psychotic Disorder [PDF]

International Journal of Environmental Research and Public Health, 2020
Introduction: First episode-psychosis (FEP) represents a stressful/traumatic event for patients. To our knowledge, no study to date has investigated thought suppression involved in FEP in a Romanian population. Our objective was to investigate thought suppression occurring during FEP within primary psychotic disorders (PPD) and substance/medication ...
Cosmin O. Popa, Razvan Predatu, Wesley C. Lee, Petronela Blaga, Eliza Sirbu, Adrian V. Rus, Alexander Clark, Cristiana Cojocaru, Alina Schenk, Vitalie Vacaras, Simona Szasz, Simona Muresan, Cristina Bredicean   +12 more
openaire   +3 more sources

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

World Psychiatry, 2015
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The primary aim of this systematic review and meta‐analysis was to assess the prevalence of MetS and its components in people with schizophrenia and related ...
D. Vancampfort, B. Stubbs, A. Mitchell, M. De Hert, M. Wampers, P. Ward, S. Rosenbaum, C. Correll   +7 more
semanticscholar   +1 more source